Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use. This clearance provides physicians ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use ...
Hosted on MSN24d
FDA grants MRI conditional label extension for Nalu Medical’s neurostimulation systemThe US Food and Drug Administration (FDA) has granted an extended label clearance for whole-body MRI-conditional use to Nalu Medical’s neurostimulation system under its previously cleared ...
CARLSBAD, Calif., January 21, 2025--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback